Differential and tumor-specific expression of CD160 in B-cell malignancies

CD160 is a human natural killer (NK)-cell–activating receptor that is also expressed on T-cell subsets. In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL...

詳細記述

保存先:
書誌詳細
出版年:Blood
主要な著者: Farren, Timothy W., Giustiniani, Jerome, Liu, Feng-Ting, Tsitsikas, Dimitris A., Macey, Marion G., Cavenagh, James D., Oakervee, Heather E., Taussig, David, Newland, Adrian C., Calaminici, Maria, Bensussan, Armand, Jenner, Michael, Gribben, John G., Agrawal, Samir G.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2011
主題:
Immunobiology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292591/
https://ncbi.nlm.nih.gov/pubmed/21715317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-334326
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料